ABEO · ISSUER CIK 318306
ABEONA THERAPEUTICS INC.
Between Aug 1, 2026 and Oct 29, 2026, 5 ABEONA THERAPEUTICS INC. insiders reported $0.00 of open-market purchases and $296K of sales on SEC Form 4.
↗5 insiders filed
Original Form 4 filings from Aug 1, 2026 to Oct 29, 2026. 0 of 5 sales were reported under a 10b5-1 plan.
$0.00Insider buying
$296KInsider selling
−$296KNet open-market
Sep 29, 2026Latest filing
| Ticker | Insider | Type | Owned | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sep 29, 202621:48 | Sep 29, 2026 | ABEO | Chief Executive Officer, Director | S · Sell | $5.16 | −19,608 | 1,286,500 | -2% | −$101K | ||
| Sep 29, 202621:48 | Sep 29, 2026 | ABEO | Chief Financial Officer | S · Sell | $5.16 | −9,191 | 482,888 | -2% | −$47K | ||
| Sep 29, 202621:48 | Sep 29, 2026 | ABEO | SVP, Chief Legal Officer | S · Sell | $5.16 | −6,727 | 421,226 | -2% | −$35K | ||
| Sep 29, 202621:47 | Sep 29, 2026 | ABEO | Chief Commercial Officer | S · Sell | $5.16 | −4,902 | 285,721 | -2% | −$25K | ||
| Sep 1, 202617:48 | Sep 1, 2026 | ABEO | Director | S · Sell | $5.86 | −15,000 | 62,065 | -19% | −$88K |